| HENDERSON MORLEY PLC Patent applications |
| Patent application number | Title | Published |
|---|
| 20100137232 | COMPOSITION COMPRISING A DIURETIC AND A CARDIAC GLYCOSIDE FOR THE TREATMENT OF DNA VIRAL INFECTIONS OF THE EYE - DNA viral infections of the eye are treated or prevented by the application of a composition including a diuretic and/or a cardiac glycoside dissolved in a water/ethanol solution wherein the level of the ethanol is adjusted to be acceptable to the eye. | 06-03-2010 |
| 20090252763 | BIOLOGICAL ADJUVANTS - A method of enhancing uptake of DNA by a host cell line comprises introducing the DNA into the host cell and contacting the host cell with non-infectious viral particles. The non-infectious particles may be L-particle or PREPS (pre-viral DNA replication envelope particles), for example, those derived from alpha herpesvirus. | 10-08-2009 |
| 20090074845 | TRANSDERMAL ACTIVE PRINCIPLE DELIVERY MEANS - A transdermal active principle delivery means comprises a skin adherent or otherwise skin-tolerant substrate applicable to a skin area affected by DNA virus, which substrate includes a composition for treating DNA comprising a transdermally effective carrier medium including at least one active principle selected from the group consisting of diuretic agents and/or cardiac glycoside agents. | 03-19-2009 |
| 20080286304 | Modifying Leukocyte Function - Use of PREPS and/or L-particles for the manufacture of a medicament for modifying or regulating leukocyte function. | 11-20-2008 |
| 20080220066 | Anti-Viral Topical Gel Formulations Containing a Diuretic Such as Furosemide and/or a Cardiac Glycoside Such as Digoxin - An anti-viral topical gel formulation comprising at least one loop diuretic and/or cardiac glycoside in a gel carrier medium, said formulation capable of transdermal delivery of the said diuretic and/or glycoside. | 09-11-2008 |
